FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Recall

Mylan, Tacrolimus Capsules 0

Mylan LLC. · Caguas, PR

Risk level
Class II
Reported by FDA
Dec 5, 2012
Recall ID
D-066-2013
Check your lot numberHow we source this data

Summary

Mylan recalled Mylan starting Jun 29, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-066-2013 on Dec 5, 2012. Reason: Failed USP Content Uniformity Requirements: OOS result reported on retained samples. Status: Terminated.

Why it was recalled

Failed USP Content Uniformity Requirements: OOS result reported on retained samples.

Product description

Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01

Lot numbers, UPCs & expiration codes

Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12

Where it was sold

Natiowide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-066-2013
Classification
Class II
Status
Terminated
Recall initiated
Jun 29, 2012
FDA report date
Dec 5, 2012
Quantity
15181 bottles.
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan LLC.

Original FDA data

Every field from FDA enforcement report D-066-2013, exactly as published.

Show all FDA fields
City
Caguas
State
PR
Status
Terminated
Country
United States
Event ID
62454
Address
Road #156, Km. 58.8, Lot 24B
Code information
Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12
Postal code
00725
Report date
Dec 5, 2012
Product type
Drugs
Recall number
D-066-2013
Classification
Class II
Recalling firm
Mylan LLC.
Product quantity
15181 bottles.
Termination date
Apr 13, 2017
Reason for recall
Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01
Distribution pattern
Natiowide
Recall initiation date
Jun 29, 2012
Initial firm notification
Letter
Center classification date
Nov 26, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-066-2013, published Dec 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls